Analysts have forecast multi-billion dollars in sales of the drug, called KarXT. A decision on its use in adults is due by September next year, and the company is also testing it to treat patients with psychosis tied to Alzheimer’s disease.
While there are several drugs for schizophrenia, KarXT belongs to a new class of drug that are likely to cause lesser side effects like weight gain.
Hmm interesting!
‘‘Analysts have forecast multi-billion dollars in sales of the drug, called KarXT. A decision on its use in adults is due by September next year, and the company is also testing it to treat patients with psychosis tied to Alzheimer’s disease.’’
Being a much larger laboratory, the distribution of the medicine and the acceleration of supply to the North American market will be rapid.
I think the price of the medicine will range between 1000 and 1500 dollars.
So much for Karxt being affordable.
It’ll be awhile before my NHS trust adopts it if it is expensive in the UK. Very crappy news on one hand, but good on the other hand because it means they expect it to sell very well.
Karxt? 5634555566
They must be convinced the drug will be approved. Most new sz meds are about $1500 a month.
This one will probably cost 9000 dollars a month
The question is if it’s effective enough to treat psychosis? How well does it work for treatment resistant schizophrenia?
I hope it works! We need something new for this horrible illness.
I read a study that it’s as about as effective as Zyprexa although I don’t know how well it works with treatment resistant patients.
Does anybody know when Europe will have it?
Probably a year or two after north america
European approval depends on European agencies. Often they are unwilling to pay high amounts for new expensive meds. Sometimes they study and negotiate for years.